Kyorin Holdings Inc
TSE:4569

Watchlist Manager
Kyorin Holdings Inc Logo
Kyorin Holdings Inc
TSE:4569
Watchlist
Price: 1 468 JPY -0.61% Market Closed
Market Cap: 84.3B JPY
Have any thoughts about
Kyorin Holdings Inc?
Write Note

Relative Value

The Relative Value of one Kyorin Holdings Inc stock under the Base Case scenario is 2 194.67 JPY. Compared to the current market price of 1 468 JPY, Kyorin Holdings Inc is Undervalued by 33%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
2 194.67 JPY
Undervaluation 33%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
96
vs Industry
75
Median 3Y
0.9
Median 5Y
0.9
Industry
2.6
Forward
0.7
vs History
88
vs Industry
26
Median 3Y
20.1
Median 5Y
18.5
Industry
23
Forward
16.2
vs History
11
vs Industry
6
Median 3Y
30.7
Median 5Y
25.2
Industry
17.8
vs History
vs Industry
Median 3Y
-20.3
Median 5Y
-20.3
Industry
25.4
vs History
96
vs Industry
68
Median 3Y
0.8
Median 5Y
0.8
Industry
2.2
vs History
84
vs Industry
79
Median 3Y
0.8
Median 5Y
0.8
Industry
2.8
Forward
0.6
vs History
63
vs Industry
74
Median 3Y
1.8
Median 5Y
1.7
Industry
5.4
vs History
80
vs Industry
38
Median 3Y
9.4
Median 5Y
8.8
Industry
13.7
Forward
7.6
vs History
73
vs Industry
30
Median 3Y
16.9
Median 5Y
14.4
Industry
17.2
vs History
11
vs Industry
7
Median 3Y
26.3
Median 5Y
21.5
Industry
16.5
vs History
vs Industry
Median 3Y
-21.2
Median 5Y
-17.6
Industry
19.3
vs History
92
vs Industry
72
Median 3Y
0.6
Median 5Y
0.6
Industry
2

Multiples Across Competitors

Competitors Multiples
Kyorin Holdings Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Kyorin Holdings Inc
TSE:4569
84.3B JPY 0.7 15.3 7.5 12.5
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
777.8B USD 19 92.9 49.9 55.6
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.2 34.9 24.3 27.7
US
Johnson & Johnson
NYSE:JNJ
367.4B USD 4.2 25 12.1 15.7
US
Merck & Co Inc
NYSE:MRK
249.6B USD 4 20.5 10.4 12.4
CH
Roche Holding AG
SIX:ROG
209.3B CHF 3.6 18.2 10.2 12.1
CH
Novartis AG
SIX:NOVN
180.7B CHF 4.2 12.7 10 14.9
UK
AstraZeneca PLC
LSE:AZN
154.9B GBP 4 30.7 169 253.3
IE
Endo International PLC
LSE:0Y5F
155B USD 66.9 -53 248.3 622.6
P/E Multiple
Earnings Growth
JP
Kyorin Holdings Inc
TSE:4569
Average P/E: 31.3
15.3
-14%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
92.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
34.9
86%
US
Johnson & Johnson
NYSE:JNJ
25
-22%
US
Merck & Co Inc
NYSE:MRK
20.5
7 336%
CH
Roche Holding AG
SIX:ROG
18.2
32%
CH
Novartis AG
SIX:NOVN
12.7
21%
UK
AstraZeneca PLC
LSE:AZN
30.7
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -53 N/A

See Also

Discover More
Back to Top